Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting
Sinovac Biotech (NASDAQ:SVA) shareholders have voted to approve significant changes in company leadership at a Special Meeting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Shareholders Voted to Approve Both SAIF Partners Proposals at Special Meeting
Newly Elected Directors Are Committed to Support and Execute the Announced Payout of Dividends and Unlock Sinovac’s Long-Term Value for All Shareholders Through the Resumption of Trading of Sinovac’s Common Shares
On July 8, 2025, at 8:00 p.m. Atlantic Standard Time, Sinovac’s incumbent Chairman Chiang Li convened, then immediately purported to adjourn, the Special Meeting without allowing shareholders to participate. SAIF Partners representatives, alongside those of other shareholders, had arrived at the Special Meeting intending to participate in the meeting.
Subsequently, the shareholder representatives present convened a continuation of the Special Meeting, chaired by incumbent Sinovac Director Mr. Yuk Lam Lo, the only remaining director on the incumbent Board approved by Privy Council. During the Special Meeting, Sinovac’s shareholders voted to approve both of SAIF Partners’ proposals, based on a tabulation of votes cast on SAIF Partners’ gold proxy card and the Company’s white proxy card.
The newly elected directors of the Company are committed to supporting and executing Sinovac’s announced payout of dividends and working closely with Sinovac’s management to unlock long-term value for all shareholders by pursuing the resumption of trading of the Company’s common shares to help Sinovac realize its tremendous potential.
About SAIF Partners
SAIF Partners is a leading Asian private equity firm with cumulative assets under management of over
View source version on businesswire.com: https://www.businesswire.com/news/home/20250708978710/en/
Media Contacts
Jonathan Gasthalter/Mark Semer/Grace Cartwright
Gasthalter & Co.
+1 (212) 257 4170
SAIF@gasthalter.com
Investor Contacts
Paul Schulman/Bill Dooley/Jon Eyl
Sodali & Co.
+ 1 (203) 658-9400
SAIF@info.sodali.com
Source: SAIF Partners IV L.P.